keyword
https://read.qxmd.com/read/38551425/literature-review-analysis-of-the-current-state-of-targeted-therapy-for-gastrointestinal-cancers
#21
JOURNAL ARTICLE
Xinge Miao, Chenxing Jin, Xiang Ji, Yibin Teng, Jiwei Liu
Globally, more than one million new cases of gastric cancer are anticipated by 2024, representing a significant unmet clinical need. It is the fourth most prevalent cancer in men and the seventh most prevalent cancer in women. The pathogens Helicobacter pylori (H. pylori) and Epstein-Barr virus (EBV) have been linked to a significant number of cases of gastric cancer. On the other hand, the recorded results were not particularly impressive because the gastrointestinal tract (GI) is frequently diagnosed at a very advanced stage, traditional treatments are not very effective, and they have several adverse side effects...
March 29, 2024: Alternative Therapies in Health and Medicine
https://read.qxmd.com/read/38542354/gastric-cancer-in-the-era-of-epigenetics
#22
REVIEW
Grigorios Christodoulidis, Konstantinos-Eleftherios Koumarelas, Marina-Nektaria Kouliou, Eleni Thodou, Maria Samara
Gastric cancer (GC) remains a significant contributor to cancer-related mortality. Novel high-throughput techniques have enlightened the epigenetic mechanisms governing gene-expression regulation. Epigenetic characteristics contribute to molecular taxonomy and give rise to cancer-specific epigenetic patterns. Helicobacter pylori (Hp) infection has an impact on aberrant DNA methylation either through its pathogenic CagA protein or by inducing chronic inflammation. The hypomethylation of specific repetitive elements generates an epigenetic field effect early in tumorigenesis...
March 16, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38538317/diverse-b-cell-tumors-associated-with-t-14-19-q32-q13-igh-bcl3-identified-by-g-banding-and-fluorescence-in-situ-hybridization
#23
JOURNAL ARTICLE
Hitoshi Ohno, Fumiyo Maekawa, Masahiko Hayashida, Miho Nakagawa, Katsuhiro Fukutsuka, Mitsuko Matsumura, Kayo Takeoka, Wataru Maruyama, Naoya Ukyo, Shinji Sumiyoshi, Yasuhiro Tanaka, Hironori Haga
We characterized 5 B-cell tumors carrying t(14;19)(q32;q13) that creates the IGH::BCL3 fusion gene. The patients' ages ranged between 55 and 88 years. Two patients presented with progression or recurrence of B-cell chronic lymphocytic leukemia (B-CLL)/small lymphocytic lymphoma (SLL), two with diffuse large B-cell lymphoma (DLBCL) of non-germinal center B-like phenotype, and the remaining one with composite angioimmunoblastic T-cell lymphoma and Epstein-Barr virus-positive DLBCL. The presence of t(14;19)(q32;q13) was confirmed by fluorescence in situ hybridization (FISH), showing colocalization of 3' IGH and 3' BCL3 probes on der(14)t(14;19) and 5' BCL3 and 5' IGH probes on der(19)t(14;19)...
2024: Journal of Clinical and Experimental Hematopathology: JCEH
https://read.qxmd.com/read/38537989/role-of-peroxiredoxin-1-induced-by-epstein-barr-virus-infection-in-nasopharyngeal-carcinoma
#24
JOURNAL ARTICLE
Min Hye Noh, Hye Young Kim, DO Hun Kim, Sung Ho Moon, Dae Young Hur
BACKGROUND/AIM: Nasopharyngeal carcinoma (NPC), a common cancer in Southern China, is associated with Epstein-Barr Virus (EBV) infection. Although many therapies for NPC have been established, the definite role of EBV in NPC remains unclear. Therefore, this work focuses on LMP2A, a latent EBV gene, and investigates whether LMP2A is related to peroxiredoxin 1 (PRDX1) in EBV-positive NPC. MATERIALS AND METHODS: The mRNA and protein expression levels of LMP2A, PRDX1, and beta-catenin were compared in patient samples...
April 2024: Anticancer Research
https://read.qxmd.com/read/38524775/cold-tumour-phenotype-explained-through-whole-genome-sequencing-in-clinical-nasopharyngeal-cancer-a-preliminary-study
#25
JOURNAL ARTICLE
Handoko, Marlinda Adham, Lisnawati Rachmadi, Heri Wibowo, Soehartati A Gondhowiardjo
INTRODUCTION: Nasopharyngeal cancer (NPC) is a complex cancer due to its unique genomic features and association with the Epstein-Barr virus (EBV). Despite therapeutic advancements, NPC prognosis remains poor, necessitating a deeper understanding of its genomics. Here, we present a comprehensive whole genome sequencing (WGS) view of NPC genomics and its correlation with the phenotype. METHODS: This study involved WGS of a clinical NPC biopsy specimen. Sequencing was carried out using a long read sequencer from Oxford Nanopore...
2024: ImmunoTargets and Therapy
https://read.qxmd.com/read/38520011/clinicopathological-and-molecular-genetic-alterations-in-monomorphic-epitheliotropic-intestinal-t-cell-lymphoma-of-the-small-intestine
#26
JOURNAL ARTICLE
Bing Zhou, Min Guo, Xiaohua Li, Ting Duan, Lizi Peng, Hua Hao
BACKGROUND: Small intestinal monomorphic-epitheliotropic intestinal T-cell lymphoma (MEITL) is a rare aggressive T-cell lymphoma originating in the gastrointestinal tract. This study aimed to investigate the clinicopathological features, immunophenotypes, and molecular genetic changes of MEITL. METHODS: The clinicopathological data for three patients with surgically resected MEITL of the small intestine were collected. Next, immunohistochemical labeling, Epstein-Barr virus (EBV) in situ hybridization, assessment of clonal rearrangement of T-cell receptor (TCR) genes, and next-generation sequencing (NGS) were performed...
March 23, 2024: European Journal of Medical Research
https://read.qxmd.com/read/38519621/analyzing-the-associations-between-tertiary-lymphoid-structures-and-postoperative-prognosis-along-with-immunotherapy-response-in-gastric-cancer-findings-from-pooled-cohort-studies
#27
JOURNAL ARTICLE
Haoxin Peng, Xiangrong Wu, Cheng Zhang, Yueting Liang, Siyuan Cheng, Honglang Zhang, Lin Shen, Yang Chen
BACKGROUND: The clinical significance of tertiary lymphoid structure (TLS) in gastric cancer (GC) was uncertain. METHODS: A systematic search was performed in public databases for eligible studies as of April 2, 2023. Meta-analyses were performed to interrogate the associations between TLS levels and prognosis and immunotherapy response of GC. Bioinformatic analyses based on the nine-gene signature of TLS were further conducted to capture the biological underpinnings...
March 22, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/38517989/the-role-of-epstein-barr-virus-ebv-infected-gastric-cancer-in-increasing-microrna124-mir-124-promoter-methylation-and-enhancer-of-zeste-homolog-2-ezh2-gene-expression
#28
JOURNAL ARTICLE
Zohreh-Al-Sadat Ghoreshi, Mohammad Rezaei Zadeh Rukerd, Hedyeh Askarpour, Ali Asghar Kheirkhah Vakilabad, Mohsen Nakhaie, Mohammad Javad Abbaszadeh Afshar, Emad Behboudi, Javad Charostad, Nasir Arefinia
The tumor suppressor microRNAs, miR-21, miR-124, and miR-494, participate in the controlling several cellular processes. To assess target miRNAs promoter methylation levels, we investigated 304 pairs of gastric cancer (GC) tissues and non-tumor tissues. We used a commercial real-time polymerase chain reaction (RT-PCR) for Epstein-Barr virus (EBV) and Helicobacter pylori kit to detect EBV and H. pylori DNA in GC tissues. After finding hypermethylation in the promoter of the miR-124 gene, we evaluated its expression level using quantitative PCR (qPCR)...
March 22, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38516642/label-free-quantitative-proteomics-reveals-the-mechanisms-of-aurora-kinase-b-in-renal-cell-carcinoma
#29
JOURNAL ARTICLE
Yulong Li, Yang Yang
BACKGROUND: Renal cell carcinoma is the most common form of kidney cancer which is a global threat to human health, needing to explore effective therapeutic targets and treatment methods. Aurora kinase B acts as an important carcinogenic role in various kinds of tumors, while its mechanism in renal cell carcinoma is indistinct. Herein we explore the underlying mechanism of Aurora kinase B in renal cell carcinoma. METHODS AND RESULTS: Label-free quantitative proteomics analysis was employed to analyze the differentially expressed proteins in 786-O cells which were treated with si-Aurora kinase B or si-ctrl...
2024: SAGE Open Medicine
https://read.qxmd.com/read/38507065/dna-methylation-profiling-identifies-epigenetic-signatures-of-early-gastric-cancer
#30
JOURNAL ARTICLE
Zhongyue Shi, Xinmeng Guo, Xiumei Hu, Ruiqi Li, Xue Li, Jun Lu, Mulan Jin, Xingran Jiang
Research on the DNA methylation status of gastric cancer (GC) has primarily focused on identifying invasive GC to develop biomarkers for diagnostic. However, DNA methylation in noninvasive GC remains unclear. We conducted a comprehensive DNA methylation profiling study of differentiated-type intramucosal GCs (IMCs). Illumina 850K microarrays were utilized to assess the DNA methylation profiles of formalin-fixed paraffin-embedded tissues from eight patients who were Epstein-Barr virus-negative and DNA mismatch repair proficient, including IMCs and paired adjacent nontumor mucosa...
March 20, 2024: Virchows Archiv: An International Journal of Pathology
https://read.qxmd.com/read/38498796/epstein-barr-virus-brlf1-induces-pd-l1-expression-in-nasopharyngeal-carcinoma-cells
#31
JOURNAL ARTICLE
Chung-Chun Wu, Mei-Shu Chen, Ting-Ying Lee, Tze-Sing Huang, Der-Yang Cho, Jen-Yang Chen
Nasopharyngeal carcinoma (NPC) is a specific human malignancy with unique geographic distribution and genetic backgrounds. Although early treatment with radio-chemotherapy has been proven effective for NPC therapy, its therapeutic efficacy substantially diminishes in the late stages of this malignancy. In the tumor microenvironment of NPC, PD-L1 has been demonstrated as a critical factor in impairing T cell activation. As an etiological role for NPC development, it is found that Epstein-Barr virus (EBV) latent proteins upregulated PD-L1 expression...
March 2024: Viral Immunology
https://read.qxmd.com/read/38490101/enhancer-infestation-drives-tumorigenic-activation-of-inactive-b-compartment-in-epstein-barr-virus-positive-nasopharyngeal-carcinoma
#32
JOURNAL ARTICLE
Harue Mizokami, Atsushi Okabe, Ruchi Choudhary, Masato Mima, Kenta Saeda, Masaki Fukuyo, Bahityar Rahmutulla, Motoaki Seki, Boon-Cher Goh, Satoru Kondo, Hirotomo Dochi, Makiko Moriyama-Kita, Kiyoshi Misawa, Toyoyuki Hanazawa, Patrick Tan, Tomokazu Yoshizaki, Melissa Jane Fullwood, Atsushi Kaneda
BACKGROUND: Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus (EBV)-associated malignant epithelial tumor endemic to Southern China and Southeast Asia. While previous studies have revealed a low frequency of gene mutations in NPC, its epigenomic aberrations are not fully elucidated apart from DNA hypermethylation. Epigenomic rewiring and enhancer dysregulation, such as enhancer hijacking due to genomic structural changes or extrachromosomal DNA, drive cancer progression. METHODS: We conducted Hi-C, 4C-seq, ChIP-seq, and RNA-seq analyses to comprehensively elucidate the epigenome and interactome of NPC using C666-1 EBV(+)-NPC cell lines, NP69T immortalized nasopharyngeal epithelial cells, clinical NPC biopsy samples, and in vitro EBV infection in HK1 and NPC-TW01 EBV(-) cell lines...
March 14, 2024: EBioMedicine
https://read.qxmd.com/read/38475709/shared-and-distinct-interactions-of-type-1-and-type-2-epstein-barr-nuclear-antigen-2-with-the-human-genome
#33
JOURNAL ARTICLE
Kenyatta C M F Viel, Sreeja Parameswaran, Omer A Donmez, Carmy R Forney, Matthew R Hass, Cailing Yin, Sydney H Jones, Hayley K Prosser, Arame A Diouf, Olivia E Gittens, Lee E Edsall, Xiaoting Chen, Hope Rowden, Katelyn A Dunn, Rui Guo, Andrew VonHandorf, Merrin Man Long Leong, Kevin Ernst, Kenneth M Kaufman, Lucinda P Lawson, Ben Gewurz, Bo Zhao, Leah C Kottyan, Matthew T Weirauch
BACKGROUND: There are two major genetic types of Epstein-Barr Virus (EBV): type 1 (EBV-1) and type 2 (EBV-2). EBV functions by manipulating gene expression in host B cells, using virus-encoded gene regulatory proteins including Epstein-Barr Nuclear Antigen 2 (EBNA2). While type 1 EBNA2 is known to interact with human transcription factors (hTFs) such as RBPJ, EBF1, and SPI1 (PU.1), type 2 EBNA2 shares only ~ 50% amino acid identity with type 1 and thus may have distinct binding partners, human genome binding locations, and functions...
March 12, 2024: BMC Genomics
https://read.qxmd.com/read/38471819/viral-reprogramming-of-host-transcription-initiation
#34
JOURNAL ARTICLE
Nathan A Ungerleider, Claire Roberts, Tina M O'Grady, Trang T Nguyen, Melody Baddoo, Jia Wang, Eman Ishaq, Monica Concha, Meggie Lam, Jordan Bass, Truong D Nguyen, Nick Van Otterloo, Nadeeshika Wickramarachchige-Dona, Dorota Wyczechowska, Maria Morales, Tianfang Ma, Yan Dong, Erik K Flemington
Viruses are master remodelers of the host cell environment in support of infection and virus production. For example, viruses typically regulate cell gene expression through modulating canonical cell promoter activity. Here, we show that Epstein Barr virus (EBV) replication causes 'de novo' transcription initiation at 29674 new transcription start sites throughout the cell genome. De novo transcription initiation is facilitated in part by the unique properties of the viral pre-initiation complex (vPIC) that binds a TATT[T/A]AA, TATA box-like sequence and activates transcription with minimal support by additional transcription factors...
March 12, 2024: Nucleic Acids Research
https://read.qxmd.com/read/38464537/targeting-latent-viral-infection-in-ebv-associated-lymphomas
#35
REVIEW
Isabella Y Kong, Lisa Giulino-Roth
Epstein-Barr virus (EBV) contributes to the development of a significant subset of human lymphomas. As a herpes virus, EBV can transition between a lytic state which is required to establish infection and a latent state where a limited number of viral antigens are expressed which allows infected cells to escape immune surveillance. Three broad latency programs have been described which are defined by the expression of viral proteins RNA, with latency I being the most restrictive expressing only EBV nuclear antigen 1 (EBNA1) and EBV-encoded small RNAs (EBERs) and latency III expressing the full panel of latent viral genes including the latent membrane proteins 1 and 2 (LMP1/2), and EBNA 2, 3, and leader protein (LP) which induce a robust T-cell response...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38462175/regulation-mechanism-of-ebv-encoded-eber1-and-lmp2a-on-yap1-and-the-impact-of-yap1-on-the-ebv-infection-status-in-ebv-associated-gastric-carcinoma
#36
JOURNAL ARTICLE
Yujie Sun, Duo Shi, Jiting Sun, Yan Zhang, Wen Liu, Bing Luo
This study aims to explore the role and regulatory mechanism of Yes-associated protein 1 (YAP1) in the development of Epstein-Barr virus-associated gastric cancer (EBVaGC). Here we showed that EBV can upregulate the expression and activity of YAP1 protein through its encoded latent products EBV-encoded small RNA 1 (EBER1) and latent membrane protein 2A (LMP2A), enhancing the malignant characteristics of EBVaGC cells. In addition, we also showed that overexpression of YAP1 induced the expression of EBV encoding latent and lytic phase genes and proteins in the epithelial cell line AGS-EBV infected with EBV, and increased the copy number of the EBV genome, while loss of YAP1 expression reduced the aforementioned indicators...
March 11, 2024: Virus Research
https://read.qxmd.com/read/38457199/comparison-of-genomic-alterations-in-epstein-barr-virus-positive-and-epstein-barr-virus-negative-diffuse-large-b-cell-lymphoma
#37
JOURNAL ARTICLE
Fang Liu, Sufang Tian, Qing Liu, Yuanfei Deng, Qingyan He, Qianyun Shi, Gang Chen, Xiuli Xu, Jiayin Yuan, Shigeo Nakamura, Kennosuke Karube, Zhe Wang
BACKGROUND: Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma (EBV-posDLBCL) is an aggressive B-cell lymphoma that often presents similar morphological and immune phenotype features to that of EBV-negative DLBCL (EBV-negDLBCL). AIMS AND METHODS: To better understand their difference in genomic landscape, we performed whole-exome sequencing (WES) of EBV-posDLBCL and EBV-negDLBCL. RESULTS: This analysis revealed a new mutational signature 17 (unknown) and signature 29 (smoking) in EBV-posDLBCL as well as a specific mutational signature 24 (associated with aflatoxin) in EBV-negDLBCL...
February 2024: Cancer Medicine
https://read.qxmd.com/read/38451208/post-cross-linked-ros-responsive-poly-%C3%AE-amino-ester-plasmid-polyplex-nps-for-gene-therapy-of-ebv-associated-nasopharyngeal-carcinoma
#38
JOURNAL ARTICLE
Caiyan Yuan, Shuangyan Chang, Chong Zhang, Dirong Dong, Jiahui Ding, Ali Reza Mahdavian, Zheng Hu, Lili Sun, Songwei Tan
Nasopharyngeal carcinoma (NPC) is one of the most common tumors in South China and Southeast Asia and is thought to be associated with Epstein-Barr virus (EBV) infection. Downregulation of latent membrane protein 1 (LMP1) encoded by EBV can reduce the expression of NF-κB and PI3K, induce apoptosis, and inhibit the growth of EBV-related NPC. For targeted cleavage of the Lmp1 oncogene via the CRISPR/Cas9 gene editing system, a post cross-linked ROS-responsive poly(β-amino ester) (PBAE) polymeric vector was developed for the delivery of CRISPR/Cas9 plasmids both in vitro and in vivo ...
March 7, 2024: Journal of Materials Chemistry. B, Materials for Biology and Medicine
https://read.qxmd.com/read/38444478/novel-plasma-microrna-expression-features-in-diagnostic-use-for-epstein-barr-virus-associated-febrile-diseases
#39
JOURNAL ARTICLE
YiFei Xu, Ying Chen, Qingluan Yang, Yuxiang Lu, Rui Zhou, Haohua Liu, Yanjie Tu, Lingyun Shao
BACKGROUND: Epstein-Barr virus (EBV) is widely infected in humans and causes various diseases. Among them, microRNAs of EBV play a key role in the progression of EBV-associated febrile diseases. There're few specific indicators for rapid differential diagnosis of various febrile diseases associated with EBV, and the lack of more reliable screening methods with high diagnostic utility has led to spaces for improvement in the accurate diagnosis and efficient treatment of relevant patients, making EBV infection a complicated clinical problem...
March 15, 2024: Heliyon
https://read.qxmd.com/read/38432126/a-novel-multiplex-real-time-pcr-assay-for-the-detection-of-cytomegalovirus-epstein-barr-virus-herpes-simplex-virus-1-2-and-strategies-for-application-to-blood-screening
#40
JOURNAL ARTICLE
Yushan Xu, Yan Lv, Mengjiao Lin, Miaomiao Li, Dawei Cui, Yongjun Wang, Cuifen Shen, Jue Xie
A multiplex real-time PCR has been developed to simultaneously detect transfusion-transmissible pathogens cytomegalovirus, Epstein-Barr virus and herpes simplex virus, as well as to provide sample quality testing, for the conserved regions of the cytomegalovirus UL123 gene, the Epstein-Barr virus BKRF1 gene, and the herpes simplex virus 1/2 UL30 gene, tested on 500 blood donors and 320 transfusion recipients. The laboratory sensitivities for all 3 pathogens were 100 copies/μL. Compared to the commercial real-time PCR reference kit, the multiplex real-time PCR assay for the detection of CMV, EBV and HSV presented 100% consistency...
February 24, 2024: Diagnostic Microbiology and Infectious Disease
keyword
keyword
120556
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.